What's new

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 18, Status: Authorised

Feb 27, 2025 - 17:17
 0
Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

BMW Group’s home plant gears up for NEUE KLASSE

Next Article

IRA tax credit repeal would drive up electricity prices, system costs: reports

Related Posts

PSUSA/00010483/202406

PSUSA/00010483/202406

Mar 6, 2025  0

Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0